Federal judge denies Bristol Myers' attempt to avoid Celgene shareholder lawsuit

Federal judge denies Bristol Myers' attempt to avoid Celgene shareholder lawsuit

Source: 
Endpoints
snippet: 

Some Celgene shareholders aren’t happy with how Bristol Myers Squibb’s takeover went down.

On Friday, a New York federal judge ruled that they have a case against the pharma giant, denying a request to dismiss allegations that it purposely slow-rolled Breyanzi’s approval to avoid paying out $6.4 billion in contingent value rights (CVR).